Thrombolytics, anticoagulants, anti-inflammatory therapy, antivirals, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin receptor blockers are among the potential treatments for COVID-19-related stroke patients (ARBs). This evidence concerns the gene ACE and stroke disorder.